Form 483

Hospira, Inc. Form 483, 2019-11-21

FDA issued a Form 483 to Hospira, Inc. on 2019-11-21 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Hospira, Inc. · Rocky Mount, United States · Issued November 21, 2019

Overview

  • 3 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Nov 2019
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Adam R Cooke, Sonya M Edmonds, Gideon N Esuzor

21 Nov 2019
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Adam R Cooke, Sonya M Edmonds, Gideon N Esuzor

21 Nov 2019
21 CFR 211.192

Written record of investigation incomplete

Cited by Adam R Cooke, Sonya M Edmonds, Gideon N Esuzor

Inspected site

HIHospira, Inc.Rocky Mount, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere